Diabetes Research and Clinical Practice
Volume 87, Issue 3 , Pages 293-301 , March 2010

Global healthcare expenditure on diabetes for 2010 and 2030

  • Ping Zhang

      Affiliations

    • Division of Diabetes Translation, Centers for Disease Control and Prevention, Atlanta, GA, USA
    • Corresponding Author InformationCorresponding author at: Division of Diabetes Translation, Centers for Disease Control and Prevention, Mailstop K-10, 4770 Buford Highway NE, Atlanta, GA, USA. Tel.: +1 770 488 5842; fax: +1 770 488 1148.
    • ,
  • Xinzhi Zhang

      Affiliations

    • Division of Diabetes Translation, Centers for Disease Control and Prevention, Atlanta, GA, USA
    • ,
  • Jonathan Brown

      Affiliations

    • Center for Health Research, Kaiser Permanente, Northwest in Portland, Oregon, Portland, OR, USA
    • ,
  • Dorte Vistisen

      Affiliations

    • Steno Diabetes Center NS, Niels Steensens Vej 2, DK-2820 Gentofte, Denmark
    • ,
  • Richard Sicree

      Affiliations

    • Baker IDI Heart and Diabetes Institute, 250 Kooyong Road, Caulfield, Victoria 3162, Australia
    • ,
  • Jonathan Shaw

      Affiliations

    • Baker IDI Heart and Diabetes Institute, 250 Kooyong Road, Caulfield, Victoria 3162, Australia
    • ,
  • Gregory Nichols

      Affiliations

    • Center for Health Research, Kaiser Permanente, Northwest in Portland, Oregon, Portland, OR, USA

Received 17 December 2009 ,Accepted 25 January 2010.

References 

  1. Shaw JE, Sicree RA, Zimment PZ. Global estimates of the prevalence of diabetes for 2110 and 2030. Diabetes Res. Clin. Pract. 2010;87(1):4–14
  2. American Diabetes Association . Economic costs of diabetes in the U.S. in 2007. Diabetes Care. 2008;31(3):596–615
  3. International Diabetes Federation . Diabetes Atlas. 2nd ed.. Brussels: International Diabetes Federation; 2003;
  4. International Diabetes Federation . Diabetes Atlas. 3rd ed.. Brussels: International Diabetes Federation; 2006;
  5. United Nations , Population Division . World Population Prospects: The 2006 Revision. Geneva: United Nations; 2007;
  6. Jonsson B. The economic impact of diabetes. Diabetes Care. 1998;21(November (Suppl. 3)):C7–C10
  7. World Health Organization. The World Health Statistics 2008, available at http://www.who.int/whosis/whostat/2008/en/index.html.
  8. Koster , von Ferber L, Ihle P, Schubert I, Hauner H. The cost burden of diabetes mellitus: the evidence from Germany—the CoDiM study. Diabetologia. 2006;49:1498–1504
  9. Jonsson B. Revealing the cost of Type II diabetes in Europe. Diabetologia. 2002;45(7):S5–S12
  10. Colagiuri S, Colagiuri R, Conway B, Grainger D, Davey P. DiabCo$t Australia: Assessing the Burden of Type 2 Diabetes in Australia. 2003;
  11. Arredondo A, Zuniga A, Parada I. Health care costs and financial costs of epidemiological changes in Latin America: evidence from Mexico. Public Health. 2005;119:711–720
  12. Wang W, Fu C, Pan C, Chen W, Zhan S, Luan R, et al. How do Type 2 diabetes mellitus-related chronic complications impact direct medical cost in four major cities of urban China?. Value Health. 2009;12(6):923–929
  13. Shobhana R, Rama RP, Lavanya A, Williams R, Vijay V, Ramachandran A. Expenditure on health care incurred by diabetic subjects in a developing country—a study from southern India. Diabetes Res. Clin. Pract. 2000;48(1):37–42
  14. Kapur A. Economic analysis of diabetes care. India J. Med. Res. 2007;125:473–482
  15. Esteghamati A, Khalilzadeh O, Anvari M, Meysamie A, Abbasi M, Forouzanfar M, et al. The economic costs of diabetes: a population-based study in Tehran. Iran. Diabetologia. 2009;52(8):1520–1527

PII: S0168-8227(10)00049-5

doi: 10.1016/j.diabres.2010.01.026

Diabetes Research and Clinical Practice
Volume 87, Issue 3 , Pages 293-301 , March 2010

Article Tools

* Image Usage & Resolution